HCA Healthcare, Inc.'s Stock Analysis

HCA Healthcare Issues $3.25 Billion in Senior Notes

HCA Inc., a wholly owned subsidiary of HCA Healthcare, has completed a public offering of $3.25 billion in senior notes, which includes four series with varying maturities and interest rates. The notes consist of $500 million due in 2030 at 4.3%, $1 billion due in 2032 at 4.6%, $1 billion due in 2035 at 4.9%, and $750 million due in 2055 at 5.7%. These notes are guaranteed on a senior unsecured basis by HCA Healthcare and will pay interest semi-annually starting May 15, 2026.

The notes rank senior in payment to any existing subordinated debt but are subordinated to any secured debt. The indentures include covenants that limit the issuer's ability to incur additional debt or engage in significant asset transactions. Additionally, in the event of a ratings downgrade and certain changes of control, noteholders have the right to require repurchase of their notes at a premium. The offering was facilitated through an underwriting agreement with several financial institutions.

Oct 31, 2025 16:15:19

HCA Healthcare Announces Public Offering of Senior Unsecured Notes

HCA Healthcare, Inc. has announced a proposed public offering of senior unsecured notes through its wholly owned subsidiary, HCA Inc. The offering is subject to market conditions, with the actual terms including maturity and interest rate to be determined at pricing. The net proceeds from this offering are intended for general corporate purposes, which may include repaying outstanding borrowings under its commercial paper program and redeeming its existing 5.875% senior notes due 2026.

On October 27, 2025, HCA Inc. notified of its intention to redeem all $1.5 billion of its 5.875% senior notes, contingent upon receiving the proceeds from the offering prior to the redemption date of November 26, 2025. The offering is being managed by several financial institutions, and additional details are available through the SEC's website and the respective managers. This announcement does not constitute an offer to sell or a solicitation to buy the senior notes.

Oct 27, 2025 16:16:44

HCA Healthcare Reports Q3 2025 Financial Results and Dividend

HCA Healthcare, Inc. announced its financial results for the third quarter of 2025, reporting revenues of $19.161 billion, a 9.6% increase from the previous year. Net income attributable to the company rose by 29.4% to $1.643 billion, translating to diluted earnings per share of $6.96, which is a 42.6% increase compared to Q3 2024. The company also noted an increase in same facility admissions and a significant rise in cash flows from operating activities, totaling $4.416 billion for the quarter.

Additionally, HCA's Board of Directors declared a quarterly cash dividend of $0.72 per share, set to be paid on December 29, 2025, to stockholders of record by December 15, 2025. The company updated its 2025 guidance, estimating capital expenditures of approximately $5.0 billion for the year, reflecting ongoing investments in operational improvements and technology. As of September 30, 2025, HCA Healthcare had total assets of $59.747 billion and total debt of $44.511 billion.

Oct 24, 2025 07:16:56

HCA Healthcare Reports Q2 2025 Results and Dividend Declaration

HCA Healthcare, Inc. announced its financial results for the second quarter of 2025, reporting revenues of $18.605 billion, a 6.4% increase from the same period in 2024. Net income rose to $1.653 billion, or $6.83 per diluted share, marking a 13.1% increase year-over-year. The company also reported an 8.4% increase in Adjusted EBITDA to $3.849 billion and significant growth in cash flows from operating activities, which totaled $4.210 billion compared to $1.971 billion in Q2 2024. Same facility admissions and equivalent admissions showed modest increases of 1.8% and 1.7%, respectively, while emergency room visits also increased slightly by 1.3%.

Additionally, HCA's Board of Directors declared a quarterly cash dividend of $0.72 per share, set to be paid on September 30, 2025, to stockholders of record by September 16, 2025. The company has $5.753 billion remaining under its share repurchase authorization and estimates capital expenditures of approximately $5.0 billion for the year. As of June 30, 2025, HCA had total assets of $59.536 billion and total debt of $44.483 billion, indicating a solid financial position amidst ongoing operations.

Jul 25, 2025 07:46:01

HCA Healthcare Appoints New Independent Director to Board

HCA Healthcare has appointed John W. Chidsey, III as an independent director, effective July 15, 2025, increasing the board's size from nine to ten members. Mr. Chidsey will serve on several committees, including the Audit and Compliance Committee and the Compensation Committee. He brings significant experience from his previous roles as CEO of Subway and Burger King Holdings, along with leadership positions at Cendant Corporation and PepsiCo.

Mr. Chidsey's appointment is expected to provide valuable insights to HCA Healthcare, which operates 192 hospitals and approximately 2,500 ambulatory care sites in 20 states and the UK. The company is recognized for its commitment to patient care and has a history of conducting clinical studies aimed at improving health outcomes. His addition to the board aligns with HCA's focus on leveraging extensive leadership experience to enhance corporate strategy.

Jul 11, 2025 16:21:03

HCA Inc. Launches $4 Billion Commercial Paper Program

HCA Inc. has established a commercial paper program allowing it to issue unsecured commercial paper notes up to a total of $4.0 billion. These notes will be unconditionally guaranteed by its parent company, HCA Healthcare, Inc., and can be borrowed, repaid, and reborrowed as needed. The proceeds from these notes will be utilized for general corporate purposes, with maturities not exceeding 397 days from the issuance date.

The notes will be sold in the U.S. commercial paper market on a private placement basis and will not be registered under the Securities Act of 1933 or state securities laws, meaning they cannot be offered or sold in the United States without proper registration or an exemption. This announcement does not constitute an offer to sell or solicit offers to buy any of the notes.

Jun 10, 2025 16:10:30

HCA Healthcare Reports Q1 2025 Financial Results and Dividend

HCA Healthcare, Inc. announced its financial results for the first quarter of 2025, reporting revenues of $18.321 billion and a net income of $1.610 billion, or $6.45 per diluted share. This marks an increase from $17.339 billion in revenues and $1.591 billion in net income, or $5.93 per diluted share, in the same quarter of 2024. The company also reported an adjusted EBITDA of $3.733 billion and a 2.6% increase in same facility admissions compared to the previous year. Cash flows from operating activities totaled $1.651 billion in the first quarter of 2025, down from $2.469 billion in the first quarter of 2024. Additionally, HCA Healthcare repurchased 7.762 million shares at a cost of $2.506 billion during this quarter, with $8.259 billion remaining under its repurchase authorization as of March 31, 2025.

The Board of Directors declared a quarterly cash dividend of $0.72 per share, scheduled to be paid on June 30, 2025, to stockholders of record as of June 16, 2025. As of March 31, 2025, HCA Healthcare's balance sheet included cash and cash equivalents of $1.060 billion and total debt of $44.576 billion. The company reaffirmed its 2025 estimated guidance ranges, reflecting expectations for volume growth and a stable operating environment. HCA Healthcare operates 192 hospitals and approximately 2,500 ambulatory sites across 20 states and the United Kingdom.

Apr 25, 2025 07:48:16

Company Enters Underwriting Agreement for Notes Issuance

The company has entered into an underwriting agreement with multiple financial institutions for the issuance and sale of Notes. This agreement involves several prominent underwriters, indicating a structured approach to raising capital in the market. The details of the agreement are included as an exhibit in the report, providing further transparency regarding the terms involved.

There are no specific financial metrics or performance indicators mentioned in the press release that highlight the company's current financial standing or future projections. The lack of detailed financial information could leave stakeholders without a clear understanding of how this agreement will impact the company's financial health.

Feb 21, 2025 16:10:38

Company Enters Material Agreement and Reports Financial Obligations

The company has entered into a material definitive agreement, which signifies a new direct financial obligation. This agreement may impact the company's financial position and obligations moving forward.

Certain schedules and exhibits related to the agreement have been omitted, but the company has committed to providing these documents to the SEC upon request. The report concludes with the necessary signatures confirming the authenticity of the information presented.

Feb 20, 2025 17:15:04

HCA Healthcare Proposes Public Offering of Senior Notes

HCA Healthcare, Inc. announced a proposed public offering of senior notes through its subsidiary, HCA Inc. The proceeds from this offering are intended for general corporate purposes, including potential repayment of existing borrowings. The offering will be managed by several financial institutions and is made under an effective shelf registration statement with the SEC, indicating a structured approach to securing funds.

However, the actual terms of the senior notes, such as maturity and interest rates, remain uncertain and will depend on market conditions at the time of pricing. This uncertainty may reflect broader market volatility and could impact the company's financial strategy. Additionally, the press release includes a disclaimer regarding forward-looking statements, emphasizing the inherent risks and uncertainties associated with such financial endeavors.

Feb 18, 2025 08:44:06